Journal Article (Review Article) DZNE-2020-04636

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Targeting intrinsically disordered proteins in rational drug discovery.

 ;

2016
Taylor & Francis Group Abingdon

Expert opinion on drug discovery 11(1), 65-77 () [10.1517/17460441.2016.1107041]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: Intrinsically disordered proteins (IDPs) and intrinsically disordered protein regions (IDPRs) have gained wide recognition over the past decade due to their versatile roles in cell physiology and pathology. A large repertoire of IDPs/IDPRs has been implicated in numerous diseases, making them potential targets for therapeutic intervention. Recent advances in experimental methods and computational approaches have enabled detection and characterization of these highly dynamic proteins at atomistic detail, thus facilitating disorder/dynamic-based drug discovery.This article presents an overview of the functional relevance and pathological implications of IDPs/IDPRs in cells. The authors outline the currently available experimental methods employed for structural characterization of these proteins. They also exemplify the practical limitations encountered during such characterization and ways to overcome them. Taken together, the article discusses the plausibility of exploiting protein disorder for drug targeting.Disorder-based drug targeting is gearing up in the realm of novel drug discovery approaches. Tools for probing the molecular features of IDPs and IDPRs are rapidly improving and start to provide accurate descriptions of the complex ensembles populated by IDPs/IDPRs. They thus pave the way for the development of drug molecules, which specifically target disease-associated disorder.

Keyword(s): Animals (MeSH) ; Drug Design (MeSH) ; Drug Discovery: methods (MeSH) ; Humans (MeSH) ; Intrinsically Disordered Proteins: metabolism (MeSH) ; Models, Molecular (MeSH) ; Molecular Targeted Therapy (MeSH) ; Protein Conformation (MeSH) ; Intrinsically Disordered Proteins

Classification:

Contributing Institute(s):
  1. Structural Biology in Dementia (AG Zweckstetter)
Research Program(s):
  1. 342 - Disease Mechanisms and Model Systems (POF3-342) (POF3-342)

Appears in the scientific report 2016
Database coverage:
Medline ; Creative Commons Attribution CC BY 4.0 ; OpenAccess ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; IF < 5 ; JCR ; NCBI Molecular Biology Database ; NationallizenzNationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Institute Collections > GÖ DZNE > GÖ DZNE-AG Zweckstetter
Document types > Articles > Journal Article
Full Text Collection
Public records
Publications Database

 Record created 2020-02-18, last modified 2024-03-21


OpenAccess:
Download fulltext PDF Download fulltext PDF (PDFA)
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)